| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,464 |
4,318 |
$490K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,836 |
2,769 |
$216K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,177 |
1,177 |
$172K |
| 87428 |
|
2,869 |
2,826 |
$84K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
837 |
837 |
$81K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,232 |
1,199 |
$61K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
772 |
766 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,201 |
1,187 |
$18K |
| 99215 |
Prolong outpt/office vis |
97 |
97 |
$15K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
145 |
145 |
$12K |
| 87430 |
|
810 |
794 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
92 |
90 |
$4K |
| 87807 |
|
270 |
268 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
66 |
64 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
77 |
77 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
45 |
44 |
$966.42 |
| 87420 |
|
78 |
78 |
$964.86 |
| 87400 |
|
56 |
56 |
$716.49 |